(Q43706694)

26 November 2017

title

Novel (4-piperidin-1-yl)-phenyl sulfonamides as potent and selective human beta(3) agonists (English)

1 reference

26 November 2017

Hu B

1

1 reference

26 November 2017

Ellingboe J

2

1 reference

26 November 2017

Han S

3

1 reference

26 November 2017

Largis E

4

1 reference

26 November 2017

Lim K

5

1 reference

26 November 2017

Malamas M

6

1 reference

26 November 2017

Mulvey R

7

1 reference

26 November 2017

Niu C

8

1 reference

26 November 2017

Oliphant A

9

1 reference

26 November 2017

Pelletier J

10

1 reference

26 November 2017

Singanallore T

11

1 reference

26 November 2017

Sum FW

12

1 reference

26 November 2017

Tillett J

13

1 reference

26 November 2017

Wong V

14

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

Bioorganic & Medicinal Chemistry

26 November 2017

published in

1 reference

26 November 2017

volume

9

1 reference

26 November 2017

issue

8

1 reference

26 November 2017

page(s)

2045-2059

1 reference

New developments in obesity

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

Pharmacological treatment of obesity: therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

Beta3-adrenergic agonists: potential therapeutics for obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

Structure and function of the beta 3-adrenergic receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

Beta 3-adrenoceptors and intestinal motility

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

Beta 3 and atypical beta-adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

L-770,644: a potent and selective human beta3 adrenergic receptor agonist with improved oral bioavailability.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

Discovery of L-755,507: a subnanomolar human beta 3 adrenergic receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

(4-Piperidin-1-yl)phenyl amides: potent and selective human beta(3) agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

Prodrugs of CL316243: a selective beta3-adrenergic receptor agonist for treating obesity and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

Pharmacological characterization of a beta 3-receptor agonist (BRL 37,344) and a partial agonist (CGP 12,177A) in neonatal rat liver plasma membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

Time of Onset of Non-Insulin-Dependent Diabetes Mellitus and Genetic Variation in the β3-Adrenergic–Receptor Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

Potent, elective human beta3 adrenergic receptor agonists containing a substituted indoline-5-sulfonamide pharmacophore

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

Discovery of a potent, orally bioavailable beta(3) adrenergic receptor agonist, (R)-N-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4 -[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

Synthesis and structure-activity relationships among .alpha.-adrenergic receptor agonists of the phenylethanolamine type

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

2,4-Thiazolidinediones as potent and selective human beta3 agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

Synthesis, binding properties, and 18F labeling of fluorocarazolol, a high-affinity beta-adrenergic receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

Structure-Activity Relationship Study of TXA2 Receptor Antagonists. 4-(2-(4-Substituted Phenylsulfonylamino)ethylthio)phenoxyacetic Acids and Related Compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

Synthesis of new sulfonylamido-penicillanic acid sulfones inhibitors of beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

The use of high-throughput synthesis and purification in the preparation of a directed library of adrenergic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

Indole-phenol bioisosterism. Synthesis and antihypertensive activity of a pyrrolo analogue of labetalol

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

Cloning of the cDNA for the human beta 1-adrenergic receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900114-6

7 January 2021

10.1016/S0968-0896(01)00114-6

Identifiers

DOI

1 reference

26 November 2017

1 reference